Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
24
|
pubmed:dateCreated |
1995-6-19
|
pubmed:abstractText |
Congenital osteopetrosis is a rare osteosclerotic bone disease characterized by both a defect in osteoclastic function and reduced generation of superoxide by leukocytes. The disease is frequently fatal during the first decade of life. A six-month trial of therapy with recombinant human interferon gamma-1b in eight patients with osteopetrosis provided evidence of benefit, prompting this study of more prolonged therapy.
|
pubmed:grant | |
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0028-4793
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
332
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1594-9
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:7753137-Adult,
pubmed-meshheading:7753137-Bone Resorption,
pubmed-meshheading:7753137-Child, Preschool,
pubmed-meshheading:7753137-Humans,
pubmed-meshheading:7753137-Injections, Subcutaneous,
pubmed-meshheading:7753137-Interferon-gamma,
pubmed-meshheading:7753137-Osteopetrosis,
pubmed-meshheading:7753137-Recombinant Proteins
|
pubmed:year |
1995
|
pubmed:articleTitle |
Long-term treatment of osteopetrosis with recombinant human interferon gamma.
|
pubmed:affiliation |
Department of Pediatric Endocrinology, Medical University of South Carolina, Charleston, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|